Sight-Threatening Immune Retinopathy Developing Secondary to Durvalumab Treatment of Small-Cell Lung Cancer: A Case Report

Sight-Threatening Immune Retinopathy Developing Secondary to Durvalumab Treatment of Small-Cell Lung Cancer: A Case Report

Introduction: Given the recent additions of immune checkpoint inhibitors (ICIs) to various cancer treatments, adverse effects, especially involving the eyes, have been on the rise. Here, we report an acute exacerbation of cancer-associated retinopathy (CAR) triggered by durvalumab treatment of small...

Full description

Bibliographic Details
Main Authors: Doah Kim, Jeong Kyeong Jang, Youngje Sung
Format: Article
Language:English
Published: Karger Publishers 2024-04-01
Series:Case Reports in Ophthalmology
Subjects:
cancer-associated retinopathy
durvalumab
immune checkpoint inhibitor
immune retinopathy
Online Access:https://beta.karger.com/Article/FullText/538246

Similar Items

Similar Items